Neonatal cystic fibrosis screeningFrom our partner site on breast cancer, MyBreastCancerNetwork.com.
Cystic fibrosis screening - neonatal; Immunoreactive trypsinogen; IRT test What the risks are: Risks associated with the test include:
Special considerations: The IRT level does not indicate the severity of the CF. False-positives may occur. References: Gross, SD, Boyle, CA, Botkin, JR, et al. Newborn Screening for Cystic Fibrosis:Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs. MMWR. 2004;53(RR13);1-36.
|
advertisement


Email this page
Printer friendly
Bookmark this page












